Israeli Health Ministry Proposes Centralized Approval for New Private Surgery Rooms Amid Sector Dispute
The Israeli Ministry of Health is advancing new regulations to control the establishment of private surgery rooms, with a parliamentary health committee set to discuss the proposal. This debate goes beyond licensing procedures, touching on a fundamental economic question: should the market or the state determine the allocation of medical resources? The issue, involving billions of shekels annually, has sparked sharp conflict between private medical entrepreneurs and doctors, who oppose the ministry and Treasury-backed initiative.
Both sides agree on key facts: there is a limited number of doctors, peripheral regions lack infrastructure, and private medicine contributes to competition, shorter wait times, and new technologies. However, the disagreement centers on how to address these challenges. Private surgery rooms serve not only private patients but also those funded by public health funds, making them part of the overall healthcare system capacity. The ministry emphasizes that the scarce resource is not the surgery room but the doctors themselves, who cannot be in both private and public sectors simultaneously. Thus, opening new rooms may simply shift existing medical staff rather than increase capacity, justifying state intervention.
Currently, private surgery rooms are allocated on a first-come, first-served basis, favoring economically lucrative central areas and neglecting the north and south. The new regulations propose a proactive state mapping of needs, with competitive tenders for establishing new rooms based on medical, economic, and public criteria. Priority would be given to clinics allocating at least 70% of their activity to publicly funded treatments, offering discounts to health funds, and demonstrating financial stability.
Private clinics and the Independent Doctors Organization criticize the plan as replacing market mechanisms with centralized planning, warning it will block new initiatives due to added conditions like public service quotas, discounts, licensing fees, and other criteria. They argue this could make investments unprofitable and favor health fund-owned clinics that can internally shift demand, undermining fair competition. Health economists counter that expanding services through health funds is more cost-effective than commercial insurance and that private medicine complements rather than replaces public care.
Both sides agree there is a systemic failure but differ on which risk is greater: market failure or regulatory failure. Given the scarcity of medical personnel, the debate focuses on how best to allocate this public resource. The concentration of private initiatives in profitable areas suggests the market alone does not meet the system’s needs. Moreover, Israeli doctors represent a public investment, making it difficult to treat them purely as private market factors.
